Review
Open access
Sep 2026
Economic Value and Cost-Effectiveness of Respiratory Syncytial Virus Vaccination in Adults: A Systematic Review
Background: Respiratory syncytial virus (RSV) is a major cause of acute respiratory infections among older adults and individuals with chronic medical conditions. Recently developed RSV vaccines have demonstrated clinical efficacy, but their economic value remains unclear across different healthcare settings and target...
Lukman Aryoseto, H. A. Haq, M. Madani et al.
· Biomedical & Pharmacolog... · 0 citations